Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
27,062,428
Share change
+1,501,658
Total reported value
$105,815,702
Price per share
$3.91
Number of holders
53
Value change
-$3,031,020
Number of buys
38
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q1 2022

As of 31 Mar 2022, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,062,428 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Sands Capital Ventures, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, Laurion Capital Management LP, PERCEPTIVE ADVISORS LLC, Woodline Partners LP, and GUARDIAN POINT CAPITAL, LP. This page lists 53 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.